Identifying the Gene Signatures from Gene-Pathway Bipartite Network Guarantees the Robust Model Performance on Predicting the Cancer Prognosis

<table>The gene-pathway bipartite network constructed with 50 gene signatures that were used for predicting the overall survival milestone outcome of acute myeloma leukemia.</table>

BioMed Research International

fig2

Figure 2

Figure 2: Identifying the Gene Signatures from Gene-Pathway Bipartite Network Guarantees the Robust Model Performance on Predicting the Cancer Prognosis 

Figure 2 | Identifying the Gene Signatures from Gene-Pathway Bipartite Network Guarantees the Robust Model Performance on Predicting the Cancer Prognosis 